Home/Filings/4/0000950170-24-038098
4//SEC Filing

Civik Thomas 4

Accession 0000950170-24-038098

CIK 0001782223other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 4:32 PM ET

Size

5.3 KB

Accession

0000950170-24-038098

Insider Transaction Report

Form 4
Period: 2024-03-26
Civik Thomas
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-26$3.83/sh+44,024$168,61244,024 total
    Exercise: $3.83Exp: 2034-03-26Common Stock (44,024 underlying)
Footnotes (1)
  • [F1]The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001723092

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:32 PM ET
Size
5.3 KB